期刊文献+

耐药金黄色葡萄球菌gyrA基因突变与中药耐药抑制剂的回复突变研究 被引量:2

Studies on Chinese medicine resistance inhibitors back mutation to Resistant Staphylococcus aureus gyrA genemutation
暂未订购
导出
摘要 探讨金黄色葡萄球菌对氟喹诺酮类的耐药与gyrA基因突变的关系及中药耐药抑制剂对gyrA基因是否具有回复突变作用,以便从分子水平初步探讨复方中药耐药抑制剂的耐药抑制分子机理。用诺氟沙星逐步诱导金黄色葡萄球菌敏感株ATCC29213,建立了MIC值为64μg/mL、128μg/mL和256μg/mL的耐药突变株;PCR扩增标准株、耐药株和中药处理的耐药株gyrA基因,产物回收纯化后送测序公司测序。gyrA基因测序结果用DNAsis软件分析表明,细菌的耐药性程度越高,碱基突变率增加;gyrA基因氨基酸序列突变分析表明,84位亲水性丝氨酸被疏水性缬氨酸取代,与细菌的高水平耐药性密切相关。中药耐药抑制剂对84位和99位氨基酸突变具有回复突变的作用。结论:中药耐药抑制剂对耐药金黄色葡萄球菌gyrA基因具有回复突变作用。 To investigate the Staphylococcus aureus resistance to fluoroquinolones with gyrA gene mu- tation and reverting role of Chinese medicine resistance inhibitor. Methods. susceptible strains of standard Staphrlococcus aureus with drug-induced a series of norfloxacin-resistance were artificially induced to resist fung. PCR amplification for gyrA of resistant strains in the treatment of resistant strains and Chinese med- icine resistance inhibitor, processing gene sequencing and sequence analysis. Result. The results show that., the higher the degree of bacterial resistance, the more mutation rate increases. In gyrA gene amino acid sequence mutation analysis, 84 status hydrophilic serine is replaced by hydrophobic valine, which closely relate to bacterial resistance. Chinese medicine resistance inhibitors have the function of reverse mutations on 84 and 99 amino acid mutated. Conclusion. Herbal drug-resistant inhibitor of high levels of drug-resistant Staphylococcus aureus gyrA gene reverting.
出处 《中国兽医杂志》 CAS 北大核心 2013年第9期3-5,共3页 Chinese Journal of Veterinary Medicine
基金 科技部国际科技合作计划专项基金(2009DFA32350)
关键词 GYRA基因 中药耐药抑制剂 回复突变作用 gyrA genemutation Chinese medicine resistance inhibitors mutation
  • 相关文献

参考文献8

二级参考文献33

  • 1雷延昌,桂希恩,冯国琴.金黄色葡萄球菌的耐药性及其耐氟喹诺酮机制的研究[J].中华内科杂志,2001,40(3):176-179. 被引量:17
  • 2雷军,王浴生,黎世能.国产氟喹诺酮药物体外耐药性研究[J].中国抗生素杂志,1993,18(3):224-228. 被引量:18
  • 3张永信,田中真由美,佐藤谦一,长田恭明.喹诺酮类抗菌药对耐甲氧西林金葡球菌DNA螺旋酶的作用[J].中国抗生素杂志,1993,18(5):338-340. 被引量:4
  • 4朱德妹,郭蓓宁,汪复.1992年上海地区细菌耐药性监测[J].中国抗生素杂志,1994,19(2):142-146. 被引量:57
  • 5Umubyeyi A N, Rigouts L, Shamputa I C, et al. Limited fluoroquinolone resistance among Mycobacteriunl tuberculosis isolates from Rwanda: results of a national survey [J]. J Antimicrobial Chemotherapy, 2007, 59 (5) : 1031 - 1033.
  • 6Huang T S, Kunin C M, Shin-Jung Lee S, et al. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwan Residents medical centre: 1995-2003 [J]. J Antimicmbial Chemotherapy, 2005, 56(6) : 1058-1062.
  • 7Takiff H E, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gryA and gyrB genes and detection of quinolone resistance mutations [J ]. Antimicrobial Agents and Chemotherapy, 1994, 38(4) : 773-780.
  • 8Guillemin I, Jarlier V, Cambau E, et al. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in Mycobacteria [J]. Antimicrobial Agents and Chemotherapy, 1998, 42(8) : 2084-2088.
  • 9Mokrousov I, Otten T, Manicheva O, et al. Molecular characterization of ofloxacin-resistance Mycobacterium tuberculosis strains from Russia [J]. Antimicrobial Agents and Chemotherapy, 2008, 52(8): 2937-2939.
  • 10Shi R, Zhang J, Li C, et al. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gryA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing [J]. J Clini Microbiology, 2006, 44(2): 4566-4568.

共引文献28

同被引文献35

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部